Ex vivo rehabilitation of non–heart-beating donor lungs in preclinical porcine model: Delayed perfusion results in superior lung function
- 1 November 2012
- journal article
- research article
- Published by Elsevier in The Journal of Thoracic and Cardiovascular Surgery
- Vol. 144 (5) , 1208-1216
Abstract
No abstract availableKeywords
Funding Information
- Roche Organ Transplant Research Foundation (58054922, T32HL007849)
- National Institutes of Health (58054922, T32HL007849)
This publication has 26 references indexed in Scilit:
- Therapeutic Hypothermia After Cardiac Arrest in Adults: Mechanism of Neuroprotection, Phases of Hypothermia, and Methods of CoolingCritical Care Clinics, 2012
- Clinical lung transplantation from uncontrolled non–heart-beating donors revisitedThe Journal of Heart and Lung Transplantation, 2012
- Adenosine A2A Agonist Improves Lung Function During Ex Vivo Lung PerfusionThe Annals of Thoracic Surgery, 2011
- Donation after cardiac death lung transplantation outcomesCurrent Opinion in Organ Transplantation, 2011
- Pretreatment strategy with adenosine A2A receptor agonist attenuates reperfusion injury in a preclinical porcine lung transplantation modelThe Journal of Thoracic and Cardiovascular Surgery, 2011
- Involvement of Adenosine A2A Receptors in Engulfment-Dependent Apoptotic Cell Suppression of InflammationThe Journal of Immunology, 2011
- Normothermic Ex Vivo Lung Perfusion in Clinical Lung TransplantationNew England Journal of Medicine, 2011
- State of the Art in Therapeutic HypothermiaAnnual Review of Medicine, 2011
- Adenosine A2A receptor activation on CD4+ T lymphocytes and neutrophils attenuates lung ischemia–reperfusion injuryThe Journal of Thoracic and Cardiovascular Surgery, 2010
- Normothermic Ex Vivo Perfusion Prevents Lung Injury Compared to Extended Cold Preservation for TransplantationAmerican Journal of Transplantation, 2009